首页|基于杨天鹏治伤理念中医传统治疗结合PKP治疗139例高龄骨质疏松性胸腰椎压缩骨折临床疗效评价研究

基于杨天鹏治伤理念中医传统治疗结合PKP治疗139例高龄骨质疏松性胸腰椎压缩骨折临床疗效评价研究

扫码查看
目的:总结中医骨伤科传统治疗方法结合经皮椎体后凸成形术(PKP)治疗高龄骨质疏松性胸腰椎压缩骨折的有效性及安全性。方法:对成都骨科医院2018 年1 月~2020 年12 月应用杨氏手法复位结合PKP治疗139 例80 岁以上高龄骨质疏松性胸腰椎压缩骨折的患者疗效进行回顾性分析。其中女性 115 例,男性 24 例,年龄 80~92 岁,伤椎 157 个椎体。收集临床治疗前后的腰背部疼痛评分数据和胸腰椎影像资料,对治疗前后疼痛视觉模拟评分(VAS)评分、PPI评分、椎体前缘高度、Cobb角,然后对收集数据进行分析研究。结果:所有患者顺利完成治疗,术后腰背部疼痛均明显缓解,出院前VAS和PPI评分均低于治疗前(P<0。01);术后复查DR侧位片上伤椎椎体前缘高度高于治疗前,而Cobb角则较治疗前减小(P<0。01)。结论:中医骨伤科传统治疗方法结合PKP治疗极具难度的高龄骨质疏松性胸腰椎压缩骨折,优势互补,安全高效。
Clinical efficacy evaluation of traditional Chinese medicine combined with PKP treatment for 139elderly patients with osteoporotic thoracolumbar vertebral compression fractures based on Yang Tianpeng's injury treatment concept
Objective:To summarize the effectiveness and safety of traditional orthopedics therapy combined with percutane-ous kyphoplasty(PKP)in the treatment of advanced osteoporotic thoracolumbar compression fractures.Methods:139patients over 80years old from January 2018to December 2020.Of which,115were female and 24were male.Age from 80to 92years,157vertebrae.Collect back and back pain score data and thoracolumbar imaging data before and after clinical treatment,and ana-lyze pain visual analog score(VAS)score,PPI score,vertebral anterior edge height,and Cobb angle before and after treatment,and then analyze the collected data.Results:All patients successfully completed treatment,back and back pain was significantly relieved,and the VAS and PPI scores were lower than before discharge(P<0.01);the height of the upper vertebra was higher than before treatment,while the Cobb angle was reduced than before treatment(P<0.01);Conclusion:Combined with PKP for the treatment of osteoporotic thoracolumbar compression fracture,complementary advantages,safe and efficient.

Yang's manual reductionPKPelderlyosteoporotic thoracolumbar compression fractureefficacy evaluation

高仰贤、曾勇、李贤斌

展开 >

成都骨科医院,四川 成都 610014

杨氏手法复位 PKP 高龄 骨质疏松性胸腰椎压缩骨折 疗效评价

2024

四川中医
四川省中医药学会,四川省中西医结合学会,四川省针灸学会,四川省中医药科学院

四川中医

CSTPCD
影响因子:0.522
ISSN:1000-3649
年,卷(期):2024.42(7)